Crystal form of gemcitabine predrug, preparation method and use of crystal form and pharmaceutical composition
A gemcitabine and composition technology, which is applied in the directions of drug combination, pharmaceutical formula, sugar derivative preparation, etc., can solve the problems of stability and bioavailability difference, affecting drug efficacy, etc., and achieves stable curative effect, easy automatic control, and convenient operation. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0044] 1. Preparation of gemcitabine prodrug compound
[0045] In a specific embodiment, the gemcitabine prodrug (formula I) used is prepared with reference to the method in patent CN102532199 and journal paper J. Med. Chem. 2016, 59, 3661-3670. The specific preparation method is as follows, but not limited to this method:
[0046] synthetic route:
[0047]
[0048] Synthesis of compound b: Dissolve 8.8g (33.5mmol) of compound a in 200ml of DMF, add 6.8g (100.5mmol) of imidazole and 5.1ml (36.9mmol) of triethylamine, and then add TBSCl in batches under ice bath. 12.7g (83.8mmol), after the addition, it was naturally raised to room temperature and reacted overnight. TLC monitoring is basically complete. The reaction was quenched by adding saturated aqueous ammonium chloride solution to the system, extracted three times with ethyl acetate (EA), combined the organic phases, washed five times with saturated brine, dried over anhydrous sodium sulfate, spin-dried, and passed through the...
Example Embodiment
[0056] Example 1
[0057] The gemcitabine prodrug crystal form of this example is the gemcitabine prodrug crystal form shown in Formula I, and the preparation method is as follows: Take 4.4g of the gemcitabine prodrug solid shown in Formula I and disperse into 800 mL ethyl acetate and 8 mL isopropanol In the mixed solvent, heated to 95°C and refluxed and stirred for 1 hour. The solids were completely dissolved. The temperature was lowered by 10°C per hour to 15°C. The crystals were precipitated out after standing for 15 hours. The filter cake was collected by filtration and dried at 30°C to obtain 1.5g Solid, ready.
[0058] The crystal prepared in this example was subjected to X-ray powder diffraction measurement under the following conditions: working voltage 35KV, tube current 30mA, angle range: 2-40°, step size: 0.01° / step, wavelength 1.5406. Its X-ray diffraction pattern is as figure 1 As shown, more detailed parameters are shown in Table 1.
[0059] Table 1 XRD peak values ...
Example Embodiment
[0063] Example 2
[0064] The gemcitabine prodrug crystal form of this example is the gemcitabine prodrug crystal form shown in formula I, and its preparation method is as follows: take 0.4 g of the gemcitabine prodrug solid shown in formula I and disperse it into 60 mL ethyl acetate and 2 mL isopropanol In the mixed solvent, heated to 80°C and refluxed for 2 hours. The solids were completely dissolved. The temperature was lowered by 10°C per hour to 15°C. After standing for 10 hours, crystals were precipitated. The filter cake was collected by filtration and dried at 30°C to obtain 0.2g Solid, ready.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap